Technology

4DMedical Limited (ASX:4DX)

Industry Group : Health Care Equipment & Services | Industry Group Name : Health Care Technology

Market Price : AUD 1.480.005 (0.339%)

(as on 2021-09-26 10:27:23)

Market Cap : AUD 435.848 M

Previous Close Open Close* Day Range 52 WEEK HIGH LOW
1.475 1.47 1.48 1.465L 1.5 H 1.12L 2.98 H
Last Trade 1.48
Change% 0.3390
52 W H/L 2.98/1.12
EBITDA 0
NPAT After Abnormal Items -21.421 M
Equity 83.357 M
ROE% -17.13%
Total Liabilities 9.28 M
Total Revenue 5.808 M
Cash and Cash Equivalents 80.88 M

Stock Information

Share price 1.48
Market Cap 435.848 M
Price/Gross Cash Flow -12.89
Dividend Yield Excluding Special 0.00%
Ending Shares 207.167 M
52-Week Range 1.12-2.98
P/E ratio 0.000
Sector P/E --
EPS -10.34
EV/EBITDA --
Net Profit Margin (%) -9,872.21%
Gross Cash Flows Per Share -0.04
Net Gearing -95.00%
Gross DPS (AUD) 0
Gross Dividend Yield (Annualized) 0.00%
Earnings Yield 0.000
Net Tangible Asset (NTA) 0.38
Sales Per Share 0.00
Book Value Per Share 0.40

Announcements

Heading Date/Time
Appendix 4G and Corporate Governance Statement  23/09/2021 8:44AM
2021 Annual Report  23/09/2021 8:44AM
4DMedical advances Australian clinical pilot with I-MED  01/09/2021 8:32AM
2021 Annual General Meeting  31/08/2021 10:54AM
FY21 Full Year Results  24/08/2021 9:03AM
Appendix 4E - Preliminary Final Report  24/08/2021 8:58AM
Change in substantial holding  23/08/2021 3:44PM
Change of interests of substantial holder - Velocimetry & HF  10/08/2021 12:49PM
Change of interests of substantial holder - 4DMedical  10/08/2021 12:45PM
4DMedical secures contract with pharmaceutical company  09/08/2021 9:20AM
Application for quotation of securities - 4DX  30/07/2021 10:05AM
Release of restricted securities from escrow  30/07/2021 9:55AM
4DMedical to present at NWR virtual investor conference  28/07/2021 9:04AM
4DMedical Investor Conference Presentation - July 2021  26/07/2021 8:17AM
Quarterly Activity Report and Appendix 4C for Q4 FY2021  26/07/2021 8:17AM
Application for quotation of securities - 4DX  30/06/2021 8:18AM
Cleansing Notice  30/06/2021 8:18AM
4DMedical Tax Exempt Employee Share Plan Rules  30/06/2021 8:18AM
4DMedical commences XV LVAS clinical trial at Johns Hopkins  29/06/2021 8:21AM
Notification regarding unquoted securities - 4DX  28/06/2021 3:00PM
4DMedical receives US$600k order for preclinical scanner  17/06/2021 8:50AM
Change of interests of substantial holder - Velocimetry & HF  07/06/2021 10:28AM
Change of interests of substantial holder - AF  07/06/2021 10:26AM
Change of interests of substantial holder - 4DMedical  07/06/2021 10:25AM
4DMedical commences patient recruitment for VQ trial  20/05/2021 8:20AM
4DMedical partners with RCI for clinical pilot program  28/04/2021 8:50AM
Quarterly Activity Report and Appendix 4C for Q3 FY2021  26/04/2021 8:56AM
4DMedical Goldman Sachs Healthcare Forum Presentation  21/04/2021 9:33AM
Appendix 3Y - BR  12/04/2021 2:20PM

Similar Companies

Related Articles

About Company

4DMedical Limited is a global med-tech company, revolutionising respiratory imaging and ventilation analysis. Its flagship XV Technology is proven and patented. The company is changing the way how physicians manage and diagnose patients with lung disorders.

Corporate Information

company address Suite 501 Level 5, 468 St Kilda Road, MELBOURNE, VIC, AUSTRALIA, 3004

company phone+61 3 9545 5940

company websitehttps://4dmedical.com/ 

Dividends

Ex-Dividend Date Franking DPS (AUD) Dividend Yield
30/06/2021 -- 0.000 0.00%
30/12/2019 -- 0.000 --

Event Calendar

Event Type Event Date Event Year
Report (Annual) 2022-09-22 2022
Report (Prelim) 2022-08-23 2022
Report (Interim) 2022-02-24 2022

Financials

Breakdown 30/06/2021 30/12/2019
Trading Revenue 216,978 --
Other Revenue 5.591 M 0
Total Revenue 5.808 M 0
Interest Income 31,161 0
Interest Expenses -2.688 M 0
Expenses -24.556 M 0
EBITDA -18.748 M 0
Depreciation and Amortization 0 0
Depreciation 0 0
Amortisation 0 0
EBIT -18.748 M 0
Pre Tax Profit -21.405 M 0
Tax Expense -15,308 0
Net Profit After Tax -21.421 M 0
Minority Interest 0 0
Preference Dividend 0 0
Net Abnormal Items 0 0
Reported Net Profit After Abnormal Items -21.421 M 0
Ending Shares 207.167 M 264.762 M
Weighted Average Shares 207.167 M 264.762 M
EPS After Abnormal Items (cents) -10.34 0
Breakdown 30/06/2021 30/12/2019
Total Current Assets 85.849 M 60.025 M
Total Non Current Assets 6.788 M 5.032 M
Total Assets 92.637 M 65.057 M
Total Current Liabilities 8.168 M 2.594 M
Total Non Current Liabilities 1.112 M 839,000
Total Liabilities 9.28 M 3.433 M
Net Assets 83.357 M 61.624 M
Breakdown 30/06/2021 30/12/2019
Net Operating Cash -14.52 M 0
Net Invested Cash -580,449 0
Net Financing Cash Flows 87.551 M 0
End Cash Position 80.88 M 0
Beginning Cash 8.429 M 0
Exchange Rate Adjustments 0 0
Other Cash Adjustments 0 0
Ending Cash 80.88 M 0

© 2021 Morningstar, Inc. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice or ‘regulated financial advice’ under New Zealand law has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Ltd, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. For more information refer to our Financial Services Guide (AU) and Financial Advice Provider Disclosure Statement (NZ) at www.morningstar.com.au/s/fsg.pdf and www.morningstar.com.au/s/fapds.pdf. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Our publications, ratings and products should be viewed as an additional investment resource, not as your sole source of information. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Some material is copyright and published under license from ASX Operations Pty Ltd ACN 004 523 782.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK